JPWO2019157056A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019157056A5 JPWO2019157056A5 JP2020542569A JP2020542569A JPWO2019157056A5 JP WO2019157056 A5 JPWO2019157056 A5 JP WO2019157056A5 JP 2020542569 A JP2020542569 A JP 2020542569A JP 2020542569 A JP2020542569 A JP 2020542569A JP WO2019157056 A5 JPWO2019157056 A5 JP WO2019157056A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- migalastat
- use according
- salt
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023192942A JP2024026080A (ja) | 2018-02-06 | 2023-11-13 | 古典型ファブリー病患者の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862626992P | 2018-02-06 | 2018-02-06 | |
| US62/626,992 | 2018-02-06 | ||
| PCT/US2019/016853 WO2019157056A1 (en) | 2018-02-06 | 2019-02-06 | Treatment of patients with classic fabry disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023192942A Division JP2024026080A (ja) | 2018-02-06 | 2023-11-13 | 古典型ファブリー病患者の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512896A JP2021512896A (ja) | 2021-05-20 |
| JPWO2019157056A5 true JPWO2019157056A5 (https=) | 2023-06-06 |
| JP2021512896A5 JP2021512896A5 (https=) | 2023-06-06 |
Family
ID=65494622
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542569A Withdrawn JP2021512896A (ja) | 2018-02-06 | 2019-02-06 | 古典型ファブリー病患者の治療 |
| JP2023192942A Pending JP2024026080A (ja) | 2018-02-06 | 2023-11-13 | 古典型ファブリー病患者の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023192942A Pending JP2024026080A (ja) | 2018-02-06 | 2023-11-13 | 古典型ファブリー病患者の治療 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20210038579A1 (https=) |
| EP (2) | EP4316589A3 (https=) |
| JP (2) | JP2021512896A (https=) |
| KR (1) | KR20200128675A (https=) |
| CN (1) | CN112203657A (https=) |
| AR (1) | AR114392A1 (https=) |
| AU (2) | AU2019217603A1 (https=) |
| DK (1) | DK3749308T3 (https=) |
| ES (1) | ES2969263T3 (https=) |
| FI (1) | FI3749308T3 (https=) |
| HR (1) | HRP20240025T1 (https=) |
| HU (1) | HUE064761T2 (https=) |
| LT (1) | LT3749308T (https=) |
| PL (1) | PL3749308T3 (https=) |
| PT (1) | PT3749308T (https=) |
| RS (1) | RS65103B1 (https=) |
| SI (1) | SI3749308T1 (https=) |
| SM (1) | SMT202400027T1 (https=) |
| TW (2) | TWI869336B (https=) |
| WO (1) | WO2019157056A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2573498T3 (es) | 2006-05-16 | 2016-06-08 | Amicus Therapeutics, Inc. | Opciones de tratamiento para la enfermedad de Fabry |
| SI3470077T1 (sl) | 2008-02-12 | 2020-12-31 | Amicus Therapeutics, Inc. | Postopek za napovedovanje odgovora na zdravljenje bolezni s farmakološkim spremljevalcem |
| CA3224537C (en) | 2017-05-30 | 2025-09-09 | Amicus Therapeutics, Inc. | USE OF MIGALASTAT IN THE TREATMENT OF PATIENTS WITH FABRY DISEASE AND RENAL FAILURE |
| CA3090496C (en) | 2018-02-06 | 2024-03-26 | Amicus Therapeutics, Inc. | Use of migalastat for treating fabry disease in pregnant patients |
| EP4282472A3 (en) | 2018-08-20 | 2024-02-21 | Amicus Therapeutics, Inc. | Methods of treating fabry disease in patients having a mutation in the gla gene |
| EP3851105B1 (en) | 2019-08-07 | 2026-03-04 | Amicus Therapeutics, Inc. | Migalastat for use in treating fabry disease in patients having a mutation in the gla gene |
| US11623916B2 (en) | 2020-12-16 | 2023-04-11 | Amicus Therapeutics, Inc. | Highly purified batches of pharmaceutical grade migalastat and methods of producing the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| ES2573498T3 (es) * | 2006-05-16 | 2016-06-08 | Amicus Therapeutics, Inc. | Opciones de tratamiento para la enfermedad de Fabry |
| AU2008232614A1 (en) | 2007-03-30 | 2008-10-09 | Amicus Therapeutics, Inc. | Method for the treatment of Fabry disease using pharmacological chaperones |
| SI3470077T1 (sl) | 2008-02-12 | 2020-12-31 | Amicus Therapeutics, Inc. | Postopek za napovedovanje odgovora na zdravljenje bolezni s farmakološkim spremljevalcem |
| KR102004114B1 (ko) * | 2016-03-22 | 2019-07-26 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Ｇｌａ 유전자에 ｇ9331ａ 돌연변이를 갖는 환자에서 파브리 질병의 치료 방법 |
| AR109103A1 (es) | 2016-07-19 | 2018-10-31 | Amicus Therapeutics Inc | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert |
| WO2019017938A1 (en) * | 2017-07-19 | 2019-01-24 | Amicus Therapeutics, Inc. | TREATMENT OF FABRY'S DISEASE IN PATIENTS WITHOUT SUBSTITUTED ENZYMATIC THERAPY (TES) AND PATIENTS SUBJECT TO TES |
-
2019
- 2019-02-06 SM SM20240027T patent/SMT202400027T1/it unknown
- 2019-02-06 RS RS20240081A patent/RS65103B1/sr unknown
- 2019-02-06 EP EP23200414.3A patent/EP4316589A3/en active Pending
- 2019-02-06 LT LTEPPCT/US2019/016853T patent/LT3749308T/lt unknown
- 2019-02-06 HU HUE19706182A patent/HUE064761T2/hu unknown
- 2019-02-06 KR KR1020207025688A patent/KR20200128675A/ko not_active Ceased
- 2019-02-06 JP JP2020542569A patent/JP2021512896A/ja not_active Withdrawn
- 2019-02-06 PL PL19706182.3T patent/PL3749308T3/pl unknown
- 2019-02-06 CN CN201980024335.8A patent/CN112203657A/zh active Pending
- 2019-02-06 EP EP19706182.3A patent/EP3749308B1/en active Active
- 2019-02-06 PT PT197061823T patent/PT3749308T/pt unknown
- 2019-02-06 DK DK19706182.3T patent/DK3749308T3/da active
- 2019-02-06 AR ARP190100287A patent/AR114392A1/es unknown
- 2019-02-06 AU AU2019217603A patent/AU2019217603A1/en not_active Abandoned
- 2019-02-06 FI FIEP19706182.3T patent/FI3749308T3/fi active
- 2019-02-06 SI SI201930691T patent/SI3749308T1/sl unknown
- 2019-02-06 ES ES19706182T patent/ES2969263T3/es active Active
- 2019-02-06 WO PCT/US2019/016853 patent/WO2019157056A1/en not_active Ceased
- 2019-02-06 HR HRP20240025TT patent/HRP20240025T1/hr unknown
- 2019-02-06 US US16/967,824 patent/US20210038579A1/en active Pending
- 2019-02-11 TW TW108104436A patent/TWI869336B/zh active
- 2019-02-11 TW TW113148020A patent/TW202537622A/zh unknown
-
2023
- 2023-11-13 JP JP2023192942A patent/JP2024026080A/ja active Pending
-
2025
- 2025-01-07 AU AU2025200074A patent/AU2025200074A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2241651T3 (es) | Utilizacion de la nicotina o de sus derivados y de la l-dopa en un medicamento destinado al tratamiento de enfermedades neurologicas, especialmente la enfermedad de parkinson. | |
| US20140329827A1 (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| JP7737367B2 (ja) | α１Ａ－ＡＲ部分アゴニストを用いて神経障害を治療するための方法 | |
| JP2021035998A5 (https=) | ||
| ES2865278T3 (es) | Amantadina para mejorar la marcha en esclerosis múltiple | |
| IL272893B1 (en) | Methods of enhancing and/or stabilizing cardiac function in patients with fabry disease | |
| KAUR et al. | Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double‐blind study | |
| Pasquier et al. | “Hemicrania continua”: The first bilateral case? | |
| Prommer | The role of fentanyl in cancer-related pain | |
| HU229150B1 (hu) | Gyorsan ható szelektív szerotonin-újrafelvételt gátlókat alkalmazó eljárások nemi mûködési zavarok kezelésére | |
| JP2015517994A (ja) | ハロフジノンの剤形およびその使用 | |
| US20080311196A1 (en) | All Day Rhinitic Condition Treatment Regimen | |
| JPWO2019157056A5 (https=) | ||
| JP2013536206A5 (https=) | ||
| US20050256131A1 (en) | Pharmaceutical active substance combination and the use thereof | |
| Akhtar et al. | Local anesthetic drugs used in dentistry | |
| JP5800485B2 (ja) | 鼻汁分泌抑制用組成物 | |
| Thompson et al. | Nonenteral routes of administration for psychiatric medications: a literature review | |
| ES2977185T3 (es) | Administración intranasal de ketamina a pacientes con cefalea en racimos | |
| EP2727595B1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| JPS5823618A (ja) | 精神分裂症を治療する組成物 | |
| WO2022238884A1 (en) | Dosing regimens | |
| NEVINS | Anaphylactoid reaction following administration of one meprobamate tablet | |
| US7608625B2 (en) | Method for treating bruxism and bruxism-related diseases | |
| EP3711759B1 (en) | Blend containing aripiprazole and a carbamate compound for prevention, mitigation, or treatment of schizophrenia |